Entity Details

Primary name PPA5_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP13686
EntryNamePPA5_HUMAN
FullNameTartrate-resistant acid phosphatase type 5
TaxID9606
Evidenceevidence at protein level
Length325
SequenceStatuscomplete
DateCreated1990-01-01
DateModified2021-06-02

Ontological Relatives

GenesACP5

GO terms

Show/Hide Table
GOName
GO:0001503 ossification
GO:0003993 acid phosphatase activity
GO:0005764 lysosome
GO:0005829 cytosol
GO:0006771 riboflavin metabolic process
GO:0008198 ferrous iron binding
GO:0008199 ferric iron binding
GO:0016021 integral component of membrane
GO:0045453 bone resorption

Subcellular Location

Show/Hide Table
Subcellular Location
Lysosome

Domains

Show/Hide Table
DomainNameCategoryType
IPR004843 Calcineurin-like phosphoesterase domain, ApaH typeDomainDomain
IPR024927 Purple acid phosphataseFamilyFamily
IPR029052 Metallo-dependent phosphatase-likeFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
607944 OMIMSpondyloenchondrodysplasia with immune dysregulation (SPENCDI)A disease characterized by vertebral and metaphyseal dysplasia, spasticity with cerebral calcifications, and strong predisposition to autoimmune diseases. The skeletal dysplasia is characterized by radiolucent and irregular spondylar and metaphyseal lesions that represent islands of chondroid tissue within bone. The disease is caused by variants affecting the gene represented in this entry. ACP5 inactivating mutations result in a functional excess of phosphorylated osteopontin causing deregulation of osteopontin signaling and consequential autoimmune disease.

Interactions

11 interactions